Mehdi Djekidel, Beata Planeta, Tore Eid, Hitten Zaveri, Irina Goncharova, Keunpoong Lim, David Labaree, Yiyun Huang, Dennis Spencer and Richard E Carson
Introduction: mGluR5 availability in medically refractory epilepsy patients compared to healthy controls (HC) using the PET agent 18F-FPEB was assessed.
Methods: Five epilepsy patients (mean age: 33.6; SD: 13.04); (4F, 1M) and 8 HC (mean age: 24.4; SD of 4.8); (5 M, 3 F) were studied with a High-Resolution Research Tomography and a bolus/infusion technique. Volume of distribution corrected for plasma free fraction values (VT/fp) was determined from equilibrium data in different brain regions including the seizure onset zone (SOZ), which was determined at an epilepsy surgical conference.
Results: A trend towards global decreases in 18F-FPEB VT/fp was noted. Significant decreases were seen in the frontal lobes, and limbic structures: The amygdala, hippocampi, and thalami compared to HC. No significant differences were found between SOZ and a contralateral mirror region.
Conclusion: 18F-FPEB human imaging of the mGluR5 system in refractory epilepsy showed significant decreases in the frontal lobes and limbic structures.
PDFShare this article
Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report
